Rainbow Children's Medicare Limited

NSEI:RAINBOW Rapporto sulle azioni

Cap. di mercato: ₹159.8b

Rainbow Children's Medicare Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Ramesh Kancharla

Amministratore delegato

₹68.1m

Compenso totale

Percentuale dello stipendio del CEO100.0%
Mandato del CEO26.3yrs
Proprietà del CEO42.3%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione5.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Oct 30
Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Sep 24
Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Sep 06
Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Aug 16
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Jun 26
Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

May 27
Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

May 23
Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

May 07
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Mar 20
Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Feb 13
Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Jan 18
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Nov 07
Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

Oct 18
Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

Aug 29
A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Jul 08
With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 18
Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Feb 11
Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

Sep 20
Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ramesh Kancharla rispetto agli utili di Rainbow Children's Medicare?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

₹2b

Jun 30 2024n/an/a

₹2b

Mar 31 2024₹68m₹68m

₹2b

Dec 31 2023n/an/a

₹2b

Sep 30 2023n/an/a

₹2b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹68m₹68m

₹2b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹2b

Jun 30 2022n/an/a

₹1b

Mar 31 2022₹60m₹59m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹972m

Jun 30 2021n/an/a

₹642m

Mar 31 2021₹78mn/a

₹400m

Mar 31 2020₹72mn/a

₹549m

Mar 31 2019₹70mn/a

₹443m

Compensazione vs Mercato: La retribuzione totale di Ramesh ($USD 805.42K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 502.40K ).

Compensazione vs guadagni: La retribuzione di Ramesh è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Ramesh Kancharla (63 yo)

26.3yrs

Mandato

₹68,054,068

Compensazione

Dr. Ramesh Kancharla, MD, PEDS, MRCP (UK) MRCPCH (UK) founded Rainbow Hospitals Limited in 1996 and serves as its Managing Director and Chairman. He has been Director of Rainbow Children's Medicare Limited...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Ramesh Kancharla
Founder26.3yrs₹68.05m42.3%
₹ 67.6b
Dinesh Chirla
Whole-Time Director18.9yrs₹35.24m6.53%
₹ 10.4b
Santanu Mukherjee
Independent Non-Executive Director3.1yrs₹2.40mNessun dato
Sundari Pisupati
Independent Non-Executive Director3.2yrs₹2.15mNessun dato
Aluri Rao
Independent Non-Executive Director5.7yrs₹1.80mNessun dato
Anil Dhawan
Independent Non-Executive Director6.3yrs₹2.15mNessun dato
Adarsh Kancharla
Non-Executive Directorless than a yearNessun datoNessun dato

5.7yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RAINBOW sono considerati esperti (durata media dell'incarico 5.7 anni).